Medicare Enrolled

Dr. Neha Pagidipati, MD

Cardiovascular Disease · Durham, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2301 ERWIN ST, Durham, NC 27710
9196848111
Registered in NPPES since 2008
NPI: 1699933234 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pagidipati from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pagidipati? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pagidipati

Dr. Neha Pagidipati is a cardiovascular disease specialist in Durham, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Pagidipati performed 242 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Pagidipati received a total of $271,660 from 19 pharmaceutical and/or device companies across 193 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pagidipati is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ 242 Medicare services $271,660 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
242
Medicare services
Bottom 11% in NC for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
120 $86 $255
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
35 $97 $328
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
31 $91 $250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
26 $106 $390
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $50 $172
Emergency department visit, moderate complexity
An emergency department visit for an established or new patient involving a moderate level of medical decision making.
15 $92 $351
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$271,660
Total received (2018-2024)
Avg $38,809/year across 7 years
Top 2% in NC for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
19
Companies
193
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$100,465
2023
$67,085
2022
$21,464
2021
$21,005
2020
$35,696
2019
$25,598
2018
$347

Payments by company (2024)

Novo Nordisk Inc
$18,391
Boehringer Ingelheim Pharmaceuticals, Inc.
$17,539
Amgen Inc.
$16,785
Novo Nordisk AS
$13,541
Boehringer Ingelheim International GmbH
$7,940
Eli Lilly and Company
$7,500
Corcept Therapeutics
$6,165
Merck Sharp & Dohme LLC
$4,047
AstraZeneca UK Limited
$3,759
AstraZeneca Pharmaceuticals LP
$2,992
Esperion Therapeutics, Inc.
$1,476
AstraZeneca AB
$135
Alnylam Pharmaceuticals Inc.
$116
Janssen Research & Development, LLC
$60
Novartis Pharmaceuticals Corporation
$20
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim International GmbH
$55,296
Boehringer Ingelheim Pharmaceuticals, Inc.
$42,353
Novo Nordisk Inc
$33,746
Eli Lilly and Company
$33,640
Novo Nordisk AS
$20,666
AstraZeneca Pharmaceuticals LP
$18,956
Amgen Inc.
$16,815
Merck Sharp & Dohme LLC
$11,406
AstraZeneca UK Limited
$9,524
Bayer Healthcare Pharmaceuticals Inc.
$8,981
Corcept Therapeutics
$6,215
Novo Nordisk Health Care AG
$6,200
Lilly USA, LLC
$3,000
Novartis Pharmaceuticals Corporation
$2,104
Esperion Therapeutics, Inc.
$1,607
Janssen Research & Development, LLC
$552
Bayer HealthCare Pharmaceuticals Inc.
$296
Alnylam Pharmaceuticals Inc.
$170
AstraZeneca AB
$135
Top 3 companies account for 48.4% of all-time payments
Associated products mentioned in payments ›
BYDUREON · FARXIGA · JARDIANCE · Kerendia · Korlym · LEQVIO · NEXLETOL · NEXLIZET · Repatha · Victoza
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a cardiovascular disease specialist in Durham?
Compare cardiologists in the Durham area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pagidipati is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pagidipati experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pagidipati performed 120 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pagidipati receive payments from pharmaceutical companies?
Yes. Dr. Pagidipati received a total of $271,660 from 19 companies across 193 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pagidipati's costs compare to other cardiologists in Durham?
Dr. Pagidipati's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pagidipati) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →